NO991097L - Nye fremgangsmÕter - Google Patents

Nye fremgangsmÕter

Info

Publication number
NO991097L
NO991097L NO991097A NO991097A NO991097L NO 991097 L NO991097 L NO 991097L NO 991097 A NO991097 A NO 991097A NO 991097 A NO991097 A NO 991097A NO 991097 L NO991097 L NO 991097L
Authority
NO
Norway
Prior art keywords
new procedures
new
procedures
idoxifene
new method
Prior art date
Application number
NO991097A
Other languages
English (en)
Other versions
NO991097D0 (no
Inventor
Jeremy N Bradbeer
Maxine Gowen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO991097L publication Critical patent/NO991097L/no
Publication of NO991097D0 publication Critical patent/NO991097D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Det beskrives en ny metode for behandling av osteoporose. Idoxifene er den foretrukne forbindelse.
NO991097A 1996-09-06 1999-03-05 Nye fremgangsmÕter NO991097D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2543996P 1996-09-06 1996-09-06
US5066697P 1997-06-24 1997-06-24
PCT/US1997/015474 WO1998009519A1 (en) 1996-09-06 1997-09-03 Method of treating post menopausal diseases, including osteoporosis

Publications (2)

Publication Number Publication Date
NO991097L true NO991097L (no) 1999-03-05
NO991097D0 NO991097D0 (no) 1999-03-05

Family

ID=26699738

Family Applications (2)

Application Number Title Priority Date Filing Date
NO991097A NO991097D0 (no) 1996-09-06 1999-03-05 Nye fremgangsmÕter
NO991096A NO991096D0 (no) 1996-09-06 1999-03-05 Nye fremgangsmÕter

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO991096A NO991096D0 (no) 1996-09-06 1999-03-05 Nye fremgangsmÕter

Country Status (16)

Country Link
EP (2) EP0927029A4 (no)
JP (2) JP2002515046A (no)
KR (2) KR20000068472A (no)
CN (2) CN1236313A (no)
AR (1) AR008155A1 (no)
AU (2) AU4247397A (no)
BR (2) BR9711681A (no)
CA (2) CA2264943A1 (no)
CO (2) CO5070658A1 (no)
CZ (1) CZ76699A3 (no)
IL (1) IL128645A0 (no)
NO (2) NO991097D0 (no)
PL (2) PL332278A1 (no)
TR (2) TR199900504T2 (no)
TW (1) TW411273B (no)
WO (2) WO1998009519A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034608A1 (en) * 1997-02-11 1998-08-13 Novo Nordisk A/S Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) * 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
DE19905961A1 (de) * 1999-02-12 2000-08-17 Stefan Neubauer Verwendung von Östrogenen zur Behandlung der Herzinsuffizienz
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
IL145876A0 (en) 2000-10-17 2002-07-25 Pfizer Prod Inc Methods and kits for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2196003A (en) * 1986-09-11 1988-04-20 Nat Res Dev Iodo-and bromo-tamoxifen derivatives
ATE162516T1 (de) * 1992-09-15 1998-02-15 Merrell Pharma Inc Nichtmetabolisierbare clomiphene-analoge zur behandlung von tamoxifen-resistenten tumoren
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
CA2223595C (en) * 1995-06-07 2008-08-05 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
CA2264943A1 (en) 1998-03-12
CZ76699A3 (cs) 1999-08-11
AU4409797A (en) 1998-03-26
BR9711681A (pt) 1999-08-24
CA2264775A1 (en) 1998-03-12
NO991097D0 (no) 1999-03-05
KR20000068472A (ko) 2000-11-25
PL332038A1 (en) 1999-08-16
BR9711676A (pt) 1999-08-24
CN1236299A (zh) 1999-11-24
AR008155A1 (es) 1999-12-09
PL332278A1 (en) 1999-08-30
WO1998009519A1 (en) 1998-03-12
EP0929216A1 (en) 1999-07-21
JP2002515046A (ja) 2002-05-21
EP0927029A4 (en) 2001-06-13
TR199900506T2 (xx) 1999-07-21
AU4247397A (en) 1998-03-26
NO991096L (no) 1999-03-05
NO991096D0 (no) 1999-03-05
CO5070658A1 (es) 2001-08-28
IL128645A0 (en) 2000-01-31
KR20000068473A (ko) 2000-11-25
CO4920218A1 (es) 2000-05-29
WO1998009619A1 (en) 1998-03-12
EP0927029A1 (en) 1999-07-07
JP2002515047A (ja) 2002-05-21
TW411273B (en) 2000-11-11
TR199900504T2 (xx) 1999-06-21
CN1236313A (zh) 1999-11-24
EP0929216A4 (en) 2001-04-04

Similar Documents

Publication Publication Date Title
ATE307119T1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
ES2145915T3 (es) Derivados estereoquimicos de la wortmannina.
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
EA199700061A1 (ru) Способ получения силденафила
DE69737689D1 (de) Verwendung von pyridazinone oder phosphinoxid verbindungen zur behandlung der herzarrhythmie
DE69709938T2 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
TR199801752T2 (xx) �leri koruma ama�l� ah�ap koruyucu madde.
TR200101754T2 (tr) Farnezil protein transferaz inhibitörleri
NO991097L (no) Nye fremgangsmÕter
NO901383L (no) Maskin for automatisk anbringelse av myk pakning.
NO984245L (no) Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse
DK0404055T3 (da) Antimetastatisk virksomt stof fra den sydamerikanske igle Haementeria ghilianii
NO20000961L (no) Nye vevs-spesifikke calpainer, samt fremgangsmåte for fremstilling og anvendelse derav
DE69736180D1 (de) Behandlung von manischen erkrankungen
BR9906803A (pt) Processo para tratamento de copd
EA199700439A1 (ru) Применение производных пирролидина для лечения алкоголизма
NO990436L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
TR199900016T2 (xx) Benzo $g] kuinolin t�revleri.
NO985929L (no) Nye former av organiske salter av N'N-diacetylcystin
ES2156868T3 (es) Compuestos de arilalcoxifenoxi-imidazolina.
SE8402505L (sv) Anordning for utstyrningsbegrensning av en manoverventil
UY24621A1 (es) Nuevos compuestos
BG102535A (en) Dihydrate of (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate of 4,10 beta-diacetoxy-2 alpha-benzoyloxy-5 beta, 20-epoxy-1-hydroxy-9-oxo-19-nor-cyclopropa[g]tax-11-ene 13-alpha -yl and method for its preparaton
SE8402656L (sv) Tillsatsanordning for netdorrar

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application